Oral plasmablastic lymphoma in HIV-infected individuals-A systematic review

被引:0
作者
Sundararajan, Kavina [1 ]
Bose, Divya [1 ]
Dineshkumar, Thayalan [1 ]
Annasamy, Rameshkumar [1 ]
Krishnan, Rajkumar [1 ]
机构
[1] SRM Dent Coll, Dept Oral Pathol & Microbiol, Ramapuram Campus, Chennai 600089, Tamil Nadu, India
关键词
HIV; oral; plasmablastic lymphoma; systematic review; treatment; ACTIVE ANTIRETROVIRAL THERAPY; GINGIVAL GROWTH; CAVITY; PATIENT; MANIFESTATION; CHEMOTHERAPY; ENTITY;
D O I
10.1002/osi2.1265
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Plasmablastic lymphoma (PBL) is an uncommon and aggressive large B-cell lymphoma that affects immunocompromised individuals. The orofacial region is the most commonly affected site. The primary aim of the article was to review systematically, the cases of oral PBL and consolidate their clinic-pathological, and molecular characteristics, rehabilitation, and outcome in Human immunodeficiency virus (HIV)-infected individuals. An electronic literature search was done and 28 articles with a total of 32 cases, of which 27 patients were adults and 5 were pediatrics were included in the review based on the inclusion criteria. Oral PBL was found to be common in HIV-affected males, frequently involving the gingiva. Histopathology revealed monomorphic neoplastic atypical cells with plasmablastic features and cohesive growth patterns. Immunohistochemistry revealed strong positivity for CD138, and CD 79a. The prognosis of oral PBL in patients with HIV was poor in both adult and pediatric age groups, however, pediatric age groups showed a worse prognosis. Hence, it is crucial to correctly diagnose oral PBL, surgically treat the patients along with chemotherapy and/or radiation therapy, and start ART in HIV-positive individuals.
引用
收藏
页数:14
相关论文
共 51 条
[41]  
Stein H., 2008, WHO CLASSIFICATION T, pP256
[42]   Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group [J].
Tchernonog, E. ;
Faurie, P. ;
Coppo, P. ;
Monjanel, H. ;
Bonnet, A. ;
Genin, M. Algarte ;
Mercier, M. ;
Dupuis, J. ;
Bijou, F. ;
Herbaux, C. ;
Delmer, A. ;
Fabiani, B. ;
Besson, C. ;
Le Gouill, S. ;
Gyan, E. ;
Laurent, C. ;
Ghesquieres, H. ;
Cartron, G. .
ANNALS OF ONCOLOGY, 2017, 28 (04) :843-848
[43]  
Tian Y, 2023, REV ESP MED NUCL IMA, V42, P46, DOI [10.1016/j.remnie.2021.09.003, 10.1016/j.remn.2021.08.004]
[44]   Plasmablastic lymphoma of the oral cavity, a B cell-derived lymphoma associated with HIV infection: a case series [J].
Tsachouridou, Olga ;
Christoforidou, Artemis ;
Metallidis, Symeon ;
Papaioannou, Maria ;
Kollaras, Panagiotis ;
Kolokotronis, Alexandros ;
Chrysanthidis, Theofilos ;
Pilalas, Dimitrios ;
Markou, Konstantinos .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2012, 269 (06) :1713-1719
[45]   IG/MYC Rearrangements are the Main Cytogenetic Alteration in Plasmablastic Lymphomas [J].
Valera, Alexandra ;
Balague, Olga ;
Colomo, Luis ;
Martinez, Antonio ;
Delabie, Jan ;
Taddesse-Heath, Lekidelu ;
Jaffe, Elaine S. ;
Campo, Elias .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (11) :1686-1694
[46]  
Vasudevan Vijeev, 2016, Indian J Dent Res, V27, P334, DOI 10.4103/0970-9290.186229
[47]   Pediatric Plasmablastic Lymphoma: A Clinicopathologic Study [J].
Vaubell, Jalaludin I. ;
Sing, Yetish ;
Ramburan, Amsha ;
Sewram, Vikash ;
Thejpal, Rajendra ;
Rapiti, Nadine ;
Ramdial, Pratistadevi K. .
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2014, 22 (07) :607-616
[48]   Plasmablastic lymphoma in a previously undiagnosed aids patient: A case report [J].
Vieira F.O. ;
El Gandour O. ;
Buadi F.K. ;
Williams G.B. ;
Shires C.B. ;
Zafar N. .
Head and Neck Pathology, 2008, 2 (2) :92-96
[49]   Validity of 3-Tesla diffusion-weighted magnetic resonance imaging for distinction of reactive and metastatic lymph nodes in head-and-neck carcinoma [J].
Vijayalakshmi, K. ;
Raghuram, P. H. ;
Saravanan, K. ;
Krithika, C. L. ;
Kannan, A. .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (03) :587-593
[50]  
Wagner Vivian Petersen, 2016, Indian J Dent Res, V27, P559, DOI 10.4103/0970-9290.195687